Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 10225
Country/Region: Zambia
Year: 2014
Main Partner: Provincial Health Office - Eastern Province
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $2,198,292 Additional Pipeline Funding: $1,207,860

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

Zambia’s population is13, 046,508 with 1,707,731 people in Eastern Province. The HIV prevalence in the 15 to 49 year age group is 14.3% while Eastern Province is at 10.3% (ZDHS 2007).Knowledge about HIV/AIDS stands at 99% amongst the adult. Only 15 % know their HIV status.

Eastern Province has 8 districts with staffing in facilities standing at 57%; the project will aim at strengthening Health Systems and service delivery.

Eastern Provincial Health Office (EPHO) will continue to work towards accelerating of the national PMTCT program towards the goal of MTCT elimination by 2015.

Out of 227 health facilities only 196 are PMTCT sites. Using the PMTCT Base funds, EPHO will expand PMTCT services to the remaining 31 facilities. Annually 13,090 babies are exposed to HIV and MTCT is at12 %.( 2007, ZDHS).Tuberculosis is a major cause of morbidity and mortality in people living with HIV/AIDS. TB patients will be tested for HIV and vice versa.TB notification stands at 2623 and 89% of patients were counselled and tested for HIV in 2010 (EPHO, TB report 2010).

Sexually Transmitted Infections (STIs) constitute 10% of outpatient attendances. Emphasis will be on sensitizations, early detection, effective treatment of STIs and screening for HIV. Partner tracking and data management will be strengthened.

Other prevention activities are in 42 facilities of Chipata; EPHO will scale up to 15 health facilities in each of these districts: Chama, Chadiza, Mambwe and Nyimba.

Despite improvement in C&T there is need to conduct more trainings for untrained health workers.

COP12PMTCT PLUS UP $165,000 will be used to implement one-off activities intended to strengthen the base of the PMTCT program in the province for a more effective MTCT elimination drive.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $300,000
Care: TB/HIV (HVTB) $100,000
Care: Pediatric Care and Support (PDCS) $165,000
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $100,000
Treatment: Adult Treatment (HTXS) $1,283,292
Treatment: Pediatric Treatment (PDTX) $250,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
C2.1.D By Age: <15 2015 4,496
C2.1.D By Age: <15 2015 1,749
C2.1.D By Age: 15+ 2015 54,812
C2.1.D By Age: 15+ 2015 21,316
C2.1.D By Age/Sex: <15 Female 2015 2,248
C2.1.D By Age/Sex: <15 Female 2015 874
C2.1.D By Age/Sex: <15 Male 2015 2,248
C2.1.D By Age/Sex: <15 Male 2015 874
C2.1.D By Age/Sex: 15+ Female 2015 30,147
C2.1.D By Age/Sex: 15+ Female 2015 11,724
C2.1.D By Age/Sex: 15+ Male 2015 24,665
C2.1.D By Age/Sex: 15+ Male 2015 9,592
C2.1.D By Sex: Female 2015 32,395
C2.1.D By Sex: Female 2015 12,598
C2.1.D By Sex: Male 2015 26,914
C2.1.D By Sex: Male 2015 10,466
C2.1.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 59,308
C2.1.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 23,064
C2.1.D Sum of Age disaggregates 2015 59,308
C2.1.D Sum of Age disaggregates 2015 23,065
C2.1.D Sum of Age/Sex disaggregates 2015 59,308
C2.1.D Sum of Age/Sex disaggregates 2015 23,064
C2.1.D Sum of Sex disaggregates 2015 59,309
C2.1.D Sum of Sex disaggregates 2015 23,064
C2.1.D_NGI By Age: <15 2015 6,245
C2.1.D_NGI By Age: 15+ 2015 76,128
C2.1.D_NGI By Age/Sex: <15 Female 2015 3,123
C2.1.D_NGI By Age/Sex: <15 Male 2015 3,123
C2.1.D_NGI By Age/Sex: 15+ Female 2015 41,870
C2.1.D_NGI By Age/Sex: 15+ Male 2015 34,257
C2.1.D_NGI By Sex: Female 2015 44,993
C2.1.D_NGI By Sex: Male 2015 37,380
C2.1.D_NGI Number of HIV-positive individuals receiving a minimum of one clinical service 2015 82,373
C2.1.D_NGI Sum of Age disaggregates 2015 82,373
C2.1.D_NGI Sum of Age/Sex disaggregates 2015 82,373
C2.1.D_NGI Sum of Sex disaggregates 2015 82,373
C2.4.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 23,064
C2.4.D Number of HIV-positive patients who were screened for TB in HIV care or treatment setting 2015 25,536
CARE_CURR Age/sex: <1 Female 2015 98
CARE_CURR Age/sex: <1 Female 2015 253
CARE_CURR Age/sex: <1 Male 2015 98
CARE_CURR Age/sex: <1 Male 2015 253
CARE_CURR Age/sex: 1-4 Female 2015 196
CARE_CURR Age/sex: 1-4 Female 2015 505
CARE_CURR Age/sex: 1-4 Male 2015 196
CARE_CURR Age/sex: 1-4 Male 2015 505
CARE_CURR Age/sex: 10-14 Female 2015 884
CARE_CURR Age/sex: 10-14 Female 2015 2,273
CARE_CURR Age/sex: 10-14 Male 2015 688
CARE_CURR Age/sex: 10-14 Male 2015 1,768
CARE_CURR Age/sex: 15-19 Female 2015 2,063
CARE_CURR Age/sex: 15-19 Female 2015 5,304
CARE_CURR Age/sex: 15-19 Male 2015 1,866
CARE_CURR Age/sex: 15-19 Male 2015 4,799
CARE_CURR Age/sex: 20-24 Female 2015 3,339
CARE_CURR Age/sex: 20-24 Female 2015 8,587
CARE_CURR Age/sex: 20-24 Male 2015 2,357
CARE_CURR Age/sex: 20-24 Male 2015 6,061
CARE_CURR Age/sex: 25-49 Female 2015 6,875
CARE_CURR Age/sex: 25-49 Female 2015 17,679
CARE_CURR Age/sex: 25-49 Male 2015 5,795
CARE_CURR Age/sex: 25-49 Male 2015 14,901
CARE_CURR Age/sex: 5-9 Female 2015 295
CARE_CURR Age/sex: 5-9 Female 2015 758
CARE_CURR Age/sex: 5-9 Male 2015 295
CARE_CURR Age/sex: 5-9 Male 2015 758
CARE_CURR Age/sex: 50+ Female 2015 758
CARE_CURR Age/sex: 50+ Female 2015 295
CARE_CURR Age/sex: 50+ Male 2015 196
CARE_CURR Age/sex: 50+ Male 2015 505
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 3,283
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 1,277
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 3,283
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 1,277
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 32,832
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 12,768
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 26,266
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 10,214
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 25,536
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 65,664
CARE_CURR Sum of Age/Sex disaggregates 2015 65,667
CARE_CURR Sum of Age/Sex disaggregates 2015 25,536
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2015 65,664
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2015 25,536
CARE_NEW Age/sex: <1 Female 2015 90
CARE_NEW Age/sex: <1 Male 2015 90
CARE_NEW Age/sex: 1-4 Female 2015 181
CARE_NEW Age/sex: 1-4 Male 2015 181
CARE_NEW Age/sex: 10-14 Female 2015 814
CARE_NEW Age/sex: 10-14 Male 2015 633
CARE_NEW Age/sex: 15-19 Female 2015 1,900
CARE_NEW Age/sex: 15-19 Male 2015 1,719
CARE_NEW Age/sex: 20-24 Female 2015 3,076
CARE_NEW Age/sex: 20-24 Male 2015 2,171
CARE_NEW Age/sex: 25-49 Female 2015 6,333
CARE_NEW Age/sex: 25-49 Male 2015 5,337
CARE_NEW Age/sex: 5-9 Female 2015 271
CARE_NEW Age/sex: 5-9 Male 2015 271
CARE_NEW Age/sex: 50+ Female 2015 271
CARE_NEW Age/sex: 50+ Male 2015 181
CARE_NEW Aggregated Age/sex: <15 Female 2015 1,176
CARE_NEW Aggregated Age/sex: <15 Male 2015 1,176
CARE_NEW Aggregated Age/sex: 15+ Female 2015 11,760
CARE_NEW Aggregated Age/sex: 15+ Male 2015 9,408
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 23,519
CARE_NEW Sum of Age/sex disaggregates 2015 23,519
CARE_NEW Sum of Aggregated Age/sex disaggregates 2015 23,520
CARE_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 5
CARE_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR supported sites providing clinical care services 2015 90
CARE_SITE By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 27
CARE_SITE By site support type: Technical Assistance-only (TA): Total number of PEPFAR supported sites providing clinical care services 2015 50
CARE_SITE Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 32
CARE_SITE Sum of Numerator Site Support Type disaggregates 2015 32
CARE_SITE Total number of PEPFAR supported sites providing clinical care services 2015 90
CARE_SITE_den Sum of Denominator Site Support Type disaggregates 2015 140
FN_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 10
FN_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 10
FN_SITE By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 8
FN_SITE By site support type: Technical Assistance-only (TA): Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 10
FN_SITE Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 8
FN_SITE Sum of Numerator Support Type disaggregates 2015 18
FN_SITE Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 10
FN_SITE_den Sum of Denominator Support Type disaggregates 2015 20
FN_THER Age: <1 2015 36
FN_THER Age: 1-4 2015 684
FN_THER Aggregated Age: <18 2015 720
FN_THER Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2015 900
FN_THER Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2015 2,387
FN_THER Sum of Age disaggregates 2015 720
FN_THER Sum of Aggregated Age disaggregates 2015 720
FPINT_SITE By site support type: Direct Service Delivery (DSD): Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2015 89
FPINT_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported HIV service delivery points 2015 89
FPINT_SITE By site support type: Technical Assistance-only (TA): Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2015 212
FPINT_SITE By site support type: Technical Assistance-only (TA): Total number of PEPFAR-supported HIV service delivery points 2015 212
FPINT_SITE Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2015 212
FPINT_SITE Service delivery type: Clinical 2015 212
FPINT_SITE Sum of Numerator Site Support Type disaggregates 2015 301
FPINT_SITE Sum of Service Delivery Type disaggregates 2015 212
FPINT_SITE Total number of PEPFAR-supported HIV service delivery points: PMTCT, Care and Treatment 2015 212
FPINT_SITE_den Sum of Denominator Site Support Type disaggregates 2015 301
HTS_TST Age/sex: <1 Female 2015 605
HTS_TST Age/sex: <1 Female 2015 680
HTS_TST Age/sex: <1 Female 2015 75
HTS_TST Age/sex: <1 Male 2015 807
HTS_TST Age/sex: <1 Male 2015 906
HTS_TST Age/sex: <1 Male 2015 100
HTS_TST Age/sex: 1-4 Female 2015 605
HTS_TST Age/sex: 1-4 Female 2015 680
HTS_TST Age/sex: 1-4 Female 2015 75
HTS_TST Age/sex: 1-4 Male 2015 807
HTS_TST Age/sex: 1-4 Male 2015 906
HTS_TST Age/sex: 1-4 Male 2015 100
HTS_TST Age/sex: 10-14 Female 2015 6,050
HTS_TST Age/sex: 10-14 Female 2015 6,798
HTS_TST Age/sex: 10-14 Female 2015 748
HTS_TST Age/sex: 10-14 Male 2015 6,050
HTS_TST Age/sex: 10-14 Male 2015 6,798
HTS_TST Age/sex: 10-14 Male 2015 748
HTS_TST Age/sex: 15-19 Female 2015 15,731
HTS_TST Age/sex: 15-19 Female 2015 17,675
HTS_TST Age/sex: 15-19 Female 2015 1,944
HTS_TST Age/sex: 15-19 Male 2015 10,084
HTS_TST Age/sex: 15-19 Male 2015 11,330
HTS_TST Age/sex: 15-19 Male 2015 1,246
HTS_TST Age/sex: 20-24 Female 2015 62,922
HTS_TST Age/sex: 20-24 Female 2015 70,699
HTS_TST Age/sex: 20-24 Female 2015 7,777
HTS_TST Age/sex: 20-24 Male 2015 30,251
HTS_TST Age/sex: 20-24 Male 2015 33,990
HTS_TST Age/sex: 20-24 Male 2015 3,739
HTS_TST Age/sex: 25-49 Female 2015 78,653
HTS_TST Age/sex: 25-49 Female 2015 88,374
HTS_TST Age/sex: 25-49 Female 2015 9,721
HTS_TST Age/sex: 25-49 Male 2015 24,201
HTS_TST Age/sex: 25-49 Male 2015 27,192
HTS_TST Age/sex: 25-49 Male 2015 2,991
HTS_TST Age/sex: 5-9 Female 2015 202
HTS_TST Age/sex: 5-9 Female 2015 227
HTS_TST Age/sex: 5-9 Female 2015 25
HTS_TST Age/sex: 5-9 Male 2015 202
HTS_TST Age/sex: 5-9 Male 2015 227
HTS_TST Age/sex: 5-9 Male 2015 25
HTS_TST Age/sex: 50+ Female 2015 4,033
HTS_TST Age/sex: 50+ Female 2015 4,532
HTS_TST Age/sex: 50+ Female 2015 499
HTS_TST Age/sex: 50+ Male 2015 20,974
HTS_TST Age/sex: 50+ Male 2015 23,566
HTS_TST Age/sex: 50+ Male 2015 2,592
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 7,462
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 923
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 7,866
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 973
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 161,339
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 19,941
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 85,510
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 10,568
HTS_TST Aggregated Age/sex: <15 Female 2015 11,330
HTS_TST Aggregated Age/sex: <15 Male 2015 13,596
HTS_TST Aggregated Age/sex: 15+ Female 2015 158,620
HTS_TST Aggregated Age/sex: 15+ Male 2015 111,034
HTS_TST By Test Result: Negative 2015 235,959
HTS_TST By Test Result: Negative 2015 268,212
HTS_TST By Test Result: Negative 2015 29,161
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 262,177
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 294,580
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 32,405
HTS_TST Sum of Age/Sex disaggregates 2015 262,177
HTS_TST Sum of Age/Sex disaggregates 2015 294,580
HTS_TST Sum of Age/Sex disaggregates 2015 32,405
HTS_TST Sum of Aggregated Age/Sex <15 2015 15,328
HTS_TST Sum of Aggregated Age/Sex <15 2015 24,926
HTS_TST Sum of Aggregated Age/Sex <15 2015 1,896
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 246,849
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 269,654
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 30,509
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 262,177
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 294,580
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 32,405
HTS_TST Sum of Test Result disaggregates 2015 262,177
HTS_TST Sum of Test Result disaggregates 2015 288,400
HTS_TST Sum of Test Result disaggregates 2015 32,405
HTS_TST_POS By Test Result: Positive 2015 26,218
HTS_TST_POS By Test Result: Positive 2015 20,188
HTS_TST_POS By Test Result: Positive 2015 3,244
LAB_ACC By site support type: Technical Assistance-only (TA) 2015 2
LAB_ACC Number of PEPFAR-supported testing facilities (laboratories) that are recognized by national, regional, or international standards for accreditation or have achieved a minimal acceptable level towards attainment of such accreditation 2015 2
LAB_ACC Sum of Support Type disaggregates 2015 2
LAB_CAP By clinical laboratories 2015 32
LAB_CAP By site support type: Direct Service Delivery (DSD) 2015 32
LAB_CAP By site support type: Technical Assistance-only (TA) 2015 27
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2015 32
LAB_CAP Sum of Site Support Type disaggregates 2015 59
LAB_PT CD4: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2015 32
LAB_PT CD4: Number of laboratories that participate in this PT program 2015 32
LAB_PT CD4: Number of laboratories that perform this testing 2015 10
LAB_PT Early infant diagnostics: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2015 1
LAB_PT Early infant diagnostics: Number of laboratories that participate in this PT program 2015 1
LAB_PT Early infant diagnostics: Number of laboratories that perform this testing 2015 1
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2015 212
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that participate in this PT program 2015 212
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that perform this testing 2015 212
LAB_PT HIV viral load: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2015 1
LAB_PT HIV viral load: Number of laboratories that participate in this PT program 2015 1
LAB_PT HIV viral load: Number of laboratories that perform this testing 2015 1
LAB_PT Percentage of laboratories and POC testing sites that perform HIV diagnostic testing that participate and successfully pass in an analyte-specific proficiency testing (PT) program 2015 1
LAB_PT TB diagnostics (AFB microscopy, Xpert MTB/RIF, Culture/DST): Number of laboratories that achieve acceptable successful passing criteria in this PT program 2015 57
LAB_PT TB diagnostics (AFB microscopy, Xpert MTB/RIF, Culture/DST): Number of laboratories that participate in this PT program 2015 57
LAB_PT TB diagnostics (AFB microscopy, Xpert MTB/RIF, Culture/DST): Number of laboratories that perform this testing 2015 57
PMTCT_ARV Life-long ART (including Option B+) 2015 1,837
PMTCT_ARV Life-long ART (including Option B+) 2015 376
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 1,837
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 376
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 1,653
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 339
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 1,010
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 207
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 827
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 169
PMTCT_ARV Sum of New and Current disaggregates 2015 1,837
PMTCT_ARV Sum of New and Current disaggregates 2015 376
PMTCT_ARV Sum of Regimen Type disaggregates 2015 1,837
PMTCT_ARV Sum of Regimen Type disaggregates 2015 376
PMTCT_ARV_NGI Life-long ART (including Option B+) 2015 2,213
PMTCT_ARV_NGI Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 2,213
PMTCT_ARV_NGI Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 1,992
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 1,217
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 996
PMTCT_ARV_NGI Sum of New and Current disaggregates 2015 2,213
PMTCT_ARV_NGI Sum of Regimen disaggregates 2015 2,213
PMTCT_EID By infants who received a virologic test within 2 months of birth 2015 1,771
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2015 80
PMTCT_EID By infants with a positive virologic test result within 12 months of birth 2015 89
PMTCT_EID Number of HIV- positive pregnant women identified during the reporting period (include known HIV-positive women at entry into PMTCT) 2015 2,213
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2015 1,771
PMTCT_EID Sum of Infant Age disaggregates 2015 1,851
PMTCT_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women 2015 15
PMTCT_SITE By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women 2015 73
PMTCT_SITE By site support type: Technical Assistance-only (TA): Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) 2015 73
PMTCT_SITE Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women 2015 88
PMTCT_SITE Sum of Numerator Support Type disaggregates 2015 88
PMTCT_SITE Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) 2015 88
PMTCT_SITE_den Sum of Denominator Support Type disaggregates 2015 73
PMTCT_STAT By: Known positives at entry 2015 1,049
PMTCT_STAT By: Known positives at entry 2015 216
PMTCT_STAT By: Number of new positives identified 2015 787
PMTCT_STAT By: Number of new positives identified 2015 162
PMTCT_STAT Number of new ANC and L&D clients 2015 29,144
PMTCT_STAT Number of new ANC and L&D clients 2015 5,989
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 26,230
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 5,390
PMTCT_STAT Sum of Positives Status disaggregates 2015 1,836
PMTCT_STAT Sum of Positives Status disaggregates 2015 378
PMTCT_STAT_NGI By: Known positives at entry 2015 1,265
PMTCT_STAT_NGI By: Number of new positives identified 2015 949
PMTCT_STAT_NGI Number of new ANC and L&D clients 2015 35,133
PMTCT_STAT_NGI Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 31,620
PMTCT_STAT_NGI Sum of Positives Status disaggregates 2015 2,214
PP_PREV Age/sex: 10-14 Female 2015 9,500
PP_PREV Age/sex: 10-14 Male 2015 9,500
PP_PREV Age/sex: 15-19 Female 2015 11,000
PP_PREV Age/sex: 15-19 Male 2015 11,000
PP_PREV Age/sex: 20-24 Female 2015 9,500
PP_PREV Age/sex: 20-24 Male 2015 9,500
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2015 60,000
PP_PREV Sum of Age/Sex disaggregates 2015 60,000
PP_PREV Total number of people in the target population 2015 164,900
QI_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented results in the last 6 months 2015 23
QI_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, HTC 2015 23
QI_SITE By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented results in the last 6 months 2015 175
QI_SITE By site support type: Technical Assistance-only (TA): Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC 2015 189
QI_SITE Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented process results in the last 6 months 2015 23
QI_SITE Sum of Numerator Site Support Type disaggregates 2015 198
QI_SITE Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC 2015 212
QI_SITE_den Sum of Denominator Site Support Type disaggregates 2015 212
SITE_SUPP By program area/support type: Care and Support Direct Service Delivery (DSD) 2015 63
SITE_SUPP By program area/support type: Care and Support Technical Assistance-only (TA) 2015 27
SITE_SUPP By program area/support type: General Population Prevention Direct Service Delivery (DSD) 2015 50
SITE_SUPP By program area/support type: General Population Prevention Technical Assistance-only (TA) 2015 93
SITE_SUPP By program area/support type: HTC Direct Service Delivery (DSD) 2015 23
SITE_SUPP By program area/support type: HTC Technical Assistance-only (TA) 2015 189
SITE_SUPP By program area/support type: Lab Direct Service Delivery (DSD) 2015 5
SITE_SUPP By program area/support type: Lab Technical Assistance-only (TA) 2015 27
SITE_SUPP By program area/support type: PHDP/Family Planning & Integration Direct Service Delivery (DSD) 2015 23
SITE_SUPP By program area/support type: PHDP/Family Planning & Integration Technical Assistance-only (TA) 2015 189
SITE_SUPP By program area/support type: PMTCT Direct Service Delivery (DSD) 2015 15
SITE_SUPP By program area/support type: PMTCT Technical Assistance-only (TA) 2015 73
SITE_SUPP By program area/support type: TB/HIV Technical Assistance-only (TA) 2015 166
SITE_SUPP By program area/support type: Treatment Direct Service Delivery (DSD) 2015 63
SITE_SUPP By program area/support type: Treatment Technical Assistance-only (TA) 2015 27
SITE_SUPP By program area/support type: VMMC Direct Service Delivery (DSD) 2015 70
SITE_SUPP Number of unique sites supported by PEPFAR 2015 212
TB_ART Age: 0-4 2015 32
TB_ART Age: 15+ 2015 1,000
TB_ART Age: 5-14 2015 900
TB_ART Aggregated Age: <15 2015 193
TB_ART Aggregated Age: 15+ 2015 1,739
TB_ART Female 2015 1,159
TB_ART Known HIV-positive 2015 1,352
TB_ART Male 2015 773
TB_ART Newly tested 2015 580
TB_ART Sum of Aggregated Age disaggregates 2015 1,932
TB_ART Sum of Sex disaggregates 2015 1,932
TB_ART Sum of Test Status disaggregates 2015 1,932
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2015 1,932
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2015 1,932
TB_ARTSITE By site support type: Direct Service Delivery (DSD): The number of PEPFAR-supported TB basic management units 2015 13
TB_ARTSITE By site support type: Direct Service Delivery (DSD): The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period 2015 13
TB_ARTSITE By site support type: Technical Assistance-only (TA): The number of PEPFAR-supported TB basic management units 2015 53
TB_ARTSITE By site support type: Technical Assistance-only (TA): The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period 2015 48
TB_ARTSITE Sum of Numerator Site Support Type disaggregates 2015 61
TB_ARTSITE The number of PEPFAR-supported TB basic management units 2015 53
TB_ARTSITE The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period 2015 48
TB_ARTSITE_den Sum of Denominator Site Support Type disaggregates 2015 66
TB_SCREEN Age: <1 2015 100
TB_SCREEN Age: 1-4 2015 198
TB_SCREEN Age: 10-14 2015 793
TB_SCREEN Age: 15-19 2015 1,982
TB_SCREEN Age: 20-24 2015 2,875
TB_SCREEN Age: 25-49 2015 6,393
TB_SCREEN Age: 5-9 2015 297
TB_SCREEN Age: 50+ 2015 248
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2015 1,388
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2015 11,498
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 25,536
TB_SCREEN Sex: Female 2015 5,798
TB_SCREEN Sex: Male 2015 7,088
TB_SCREEN Sum of Age disaggregates 2015 3,370
TB_SCREEN Sum of Aggregated Age disaggregates 2015 12,886
TB_SCREEN Sum of Sex disaggregates 2015 12,886
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2015 12,886
TX_CURR Age/Sex: <1 Female 2015 158
TX_CURR Age/Sex: <1 Female 2015 62
TX_CURR Age/Sex: <1 Male 2015 159
TX_CURR Age/Sex: <1 Male 2015 62
TX_CURR Age/Sex: 1-4 Female 2015 1,030
TX_CURR Age/Sex: 1-4 Female 2015 400
TX_CURR Age/Sex: 1-4 Male 2015 1,030
TX_CURR Age/Sex: 1-4 Male 2015 400
TX_CURR Age/Sex: 15+ Female 2015 24,052
TX_CURR Age/Sex: 15+ Female 2015 9,354
TX_CURR Age/Sex: 15+ Male 2015 19,241
TX_CURR Age/Sex: 15+ Male 2015 7,483
TX_CURR Age/Sex: 5-14 Female 2015 1,217
TX_CURR Age/Sex: 5-14 Female 2015 473
TX_CURR Age/Sex: 5-14 Male 2015 1,217
TX_CURR Age/Sex: 5-14 Male 2015 473
TX_CURR Aggregated Age/Sex: <1 Female 2015 159
TX_CURR Aggregated Age/Sex: <1 Female 2015 62
TX_CURR Aggregated Age/Sex: <1 Male 2015 159
TX_CURR Aggregated Age/Sex: <1 Male 2015 18,707
TX_CURR Aggregated Age/Sex: <15 Female 2015 2,405
TX_CURR Aggregated Age/Sex: <15 Female 2015 935
TX_CURR Aggregated Age/Sex: <15 Male 2015 2,406
TX_CURR Aggregated Age/Sex: <15 Male 2015 935
TX_CURR Aggregated Age/Sex: 15+ Female 2015 24,052
TX_CURR Aggregated Age/Sex: 15+ Female 2015 9,354
TX_CURR Aggregated Age/Sex: 15+ Male 2015 19,241
TX_CURR Aggregated Age/Sex: 15+ Male 2015 7,483
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 48,104
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 18,707
TX_CURR Percent women and girls with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT] 2015 1
TX_CURR Sum of age/sex disaggregates 2015 1,870
TX_CURR Sum of Age/Sex disaggregations 2015 4,811
TX_CURR Sum of Aggregated Age/Sex <15 2015 4,811
TX_CURR Sum of Aggregated Age/Sex <15 2015 1,870
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 43,293
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 16,837
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 48,104
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 18,707
TX_CURR_NGI Age/Sex: <1 Female 2015 220
TX_CURR_NGI Age/Sex: <1 Male 2015 221
TX_CURR_NGI Age/Sex: 1-4 Female 2015 1,430
TX_CURR_NGI Age/Sex: 1-4 Male 2015 1,430
TX_CURR_NGI Age/Sex: 15+ Female 2015 33,406
TX_CURR_NGI Age/Sex: 15+ Male 2015 26,724
TX_CURR_NGI Age/Sex: 5-14 Female 2015 1,690
TX_CURR_NGI Age/Sex: 5-14 Male 2015 1,690
TX_CURR_NGI Aggregated Age/Sex: <1 Female 2015 220
TX_CURR_NGI Aggregated Age/Sex: <1 Male 2015 221
TX_CURR_NGI Aggregated Age/Sex: <15 Female 2015 3,340
TX_CURR_NGI Aggregated Age/Sex: <15 Male 2015 3,341
TX_CURR_NGI Aggregated Age/Sex: 15+ Female 2015 33,406
TX_CURR_NGI Aggregated Age/Sex: 15+ Male 2015 26,724
TX_CURR_NGI Number of adults and children receiving antiretroviral therapy (ART) 2015 66,811
TX_CURR_NGI Sum of Age/Sex disaggregates 2015 66,811
TX_CURR_NGI Sum of Aggregated Age/Sex <15 2015 6,681
TX_CURR_NGI Sum of Aggregated Age/Sex 15+ 2015 60,130
TX_CURR_NGI Sum of Aggregated Age/Sex disaggregates 2015 66,811
TX_DIST Number of Districts with documented routine supportive supervision visits to 75% of HIV care and treatment sites supported by the District 2015 9
TX_DIST Total number of PEPFAR supported District Health Offices 2015 9
TX_NEW Aggregated Grouping by Age: <1 Male 2015 128
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2015 128
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2015 560
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2015 560
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2015 5,600
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2015 4,480
TX_NEW Breastfeeding status 2015 2,928
TX_NEW By Age/Sex: <1 Female 2015 64
TX_NEW By Age/Sex: <1 Male 2015 64
TX_NEW By Age/Sex: 1-4 Female 2015 128
TX_NEW By Age/Sex: 1-4 Male 2015 128
TX_NEW By Age/Sex: 10-14 Female 2015 192
TX_NEW By Age/Sex: 10-14 Male 2015 192
TX_NEW By Age/Sex: 15-19 Female 2015 560
TX_NEW By Age/Sex: 15-19 Male 2015 400
TX_NEW By Age/Sex: 20-24 Female 2015 880
TX_NEW By Age/Sex: 20-24 Male 2015 560
TX_NEW By Age/Sex: 25-49 Female 2015 3,360
TX_NEW By Age/Sex: 25-49 Male 2015 2,720
TX_NEW By Age/Sex: 5-9 Female 2015 176
TX_NEW By Age/Sex: 5-9 Male 2015 176
TX_NEW By Age/Sex: 50+ Female 2015 800
TX_NEW By Age/Sex: 50+ Male 2015 800
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2015 11,200
TX_NEW Pregnancy status 2015 2,928
TX_NEW Sum of Age/Sex disaggregates 2015 11,200
TX_NEW Sum of Aggregated Age/Sex disaggregates 2015 11,200
TX_RET Age: 0-4 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 40
TX_RET Age: 15+ (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 1,260
TX_RET Age: 5-14 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 100
TX_RET Aggregated Age: <15 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 190
TX_RET Aggregated Age: 15+ (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 1,710
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2015 8,190
TX_RET Pregnancy and breastfeeding status (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 1,819
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2015 9,100
TX_RET_den Age: 0-4 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 50
TX_RET_den Age: 15+ (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 1,350
TX_RET_den Age: 5-14 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 100
TX_RET_den Aggregated Age: <15 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 200
TX_RET_den Aggregated Age: 15+ (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 1,800
TX_RET_den Pregnancy and breastfeeding status (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 1,830
TX_SITE By support type: Direct Service Delivery (DSD): Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 76
TX_SITE By support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported ART sites 2015 76
TX_SITE By support type: Technical Assistance (TA-only): Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 14
TX_SITE By support type: Technical Assistance (TA-only): Total number of PEPFAR-supported ART sites 2015 14
TX_SITE Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 90
TX_SITE Sum of Numerator Site Support Type disaggregates 2015 90
TX_SITE Total number of PEPFAR-supported ART sites 2015 90
TX_SITE_den Sum of Denominator Site Support Type disaggregates 2015 90
VMMC_AE By AE Type: Number of VMMC clients with one or more moderate or severe medical device-related AE(s) 2015 1
VMMC_AE By AE type: Number of VMMC clients with one or more moderate or severe surgical intra-operative AE(s) 2015 10
VMMC_AE By AE Type: Number of VMMC clients with one or more moderate or severe surgical post-operative AE(s) 2015 40
VMMC_AE Number of males circumcised surgically or by medical device that experienced at least one moderate or severe adverse event(s) (AEs) 2015 75
VMMC_AE Sub-Disag: By Medical device-based AE(s) by maximum severity category: Number of clients with one or more moderate medical device-related AE(s), but no severe medical device-related AE(s) 2015 1
VMMC_AE Sub-Disag: By Surgical post-operative AE(s) by maximum severity category: Number of clients with one or more moderate surgical post-operative AE(s), but no severe surgical post-operative AE(s) 2015 38
VMMC_AE Sub-Disag: By Surgical post-operative AE(s) by maximum severity category: Number of clients with one or more severe surgical intra-operative AE(s) 2015 2
VMMC_AE Sub-Disag: Surgical intra-operative AE(s) by maximum severity category: Number of clients with one or more moderate surgical intra-operative AE(s), but no severe surgical intra-operative AE(s) 2015 9
VMMC_AE Sub-Disag: Surgical intra-operative AE(s) by maximum severity category: Number of clients with one or more severe surgical intra-operative AE(s) 2015 1
VMMC_CIRC By Age: <1 2015 150
VMMC_CIRC By Age: 1-9 2015 450
VMMC_CIRC By Age: 10-14 2015 1,500
VMMC_CIRC By Age: 15-19 2015 3,750
VMMC_CIRC By Age: 20-24 2015 4,500
VMMC_CIRC By Age: 25-49 2015 4,500
VMMC_CIRC By Age: 50+ 2015 150
VMMC_CIRC By circumcision technique: Device-based VMMC 2015 15,000
VMMC_CIRC By circumcision technique: Surgical VMMC 2015 15,000
VMMC_CIRC By follow-up status: Number of surgically circumcised clients who did NOT return for follow-up care within 14 days of circumcision surgery 2015 750
VMMC_CIRC By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery 2015 14,250
VMMC_CIRC By HIV status: Number of clients with undocumented/indeterminate HIV status or not tested for HIV at site 2015 600
VMMC_CIRC By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) 2015 13,500
VMMC_CIRC By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) 2015 900
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2015 15,000
VMMC_CIRC Sum of age disaggregates 2015 15,000
VMMC_CIRC_NGI By Age: <1 2015 150
VMMC_CIRC_NGI By Age: 1-9 2015 450
VMMC_CIRC_NGI By Age: 10-14 2015 1,500
VMMC_CIRC_NGI By Age: 15-19 2015 3,750
VMMC_CIRC_NGI By Age: 20-24 2015 4,500
VMMC_CIRC_NGI By Age: 25-49 2015 4,500
VMMC_CIRC_NGI By Age: 50+ 2015 150
VMMC_CIRC_NGI By circumcision technique: Device-based VMMC 2015 15,000
VMMC_CIRC_NGI By circumcision technique: Surgical VMMC 2015 15,000
VMMC_CIRC_NGI By follow-up status: Number of surgically circumcised clients who did NOT return for follow-up care within 14 days of circumcision surgery 2015 750
VMMC_CIRC_NGI By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery 2015 14,250
VMMC_CIRC_NGI By HIV status: Number of clients with undocumented/indeterminate HIV status or not tested for HIV at site 2015 600
VMMC_CIRC_NGI By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) 2015 13,500
VMMC_CIRC_NGI By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) 2015 900
VMMC_CIRC_NGI Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2015 15,000
VMMC_CIRC_NGI Sum of Age disaggregates 2015 15,000
Cross Cutting Budget Categories and Known Amounts Total: $1,776,859
Human Resources for Health $1,156,859
Motor Vehicles: Purchased $520,000
Food and Nutrition: Policy, Tools, and Service Delivery $100,000
Key Issues Identified in Mechanism
Safe Motherhood
Tuberculosis
Workplace Programs
Family Planning